Discreet, evidence-based care for Michigan women — HSDD, perimenopause, menopausal hormone therapy, low-dose testosterone for women, and vaginal estrogen — delivered by clinicians licensed in Michigan.
OmniRx Health providers are licensed by the Michigan Board of Medicine for comprehensive telehealth services across both peninsulas.
Hypoactive sexual desire disorder affects about 1 in 10 adult women. Treatable with FDA-approved Addyi or Vyleesi, low-dose testosterone, and addressing modifiable contributors like SSRIs and contraceptive choice.
Modern menopausal hormone therapy — typically transdermal estradiol with cyclic or continuous progesterone — for hot flashes, sleep disruption, libido changes, and mood symptoms.
Local vaginal estrogen, DHEA inserts (prasterone), and ospemifene for genitourinary symptoms with very low systemic absorption.
Off-label and supported by international guidelines for postmenopausal HSDD. Carefully titrated based on baseline labs, with quarterly monitoring.
Michigan's telehealth laws support virtual care delivery with provisions for both synchronous and asynchronous services.
Michigan pharmacies in Detroit, Grand Rapids, Traverse City, and throughout the UP ensure prescription access with statewide delivery.
Visits, intake forms, and lab results are protected health information. Medication ships in plain, unmarked packaging anywhere in Michigan. If you choose cash-pay, no insurance EOB is sent to your household.